Literature DB >> 29049740

Phenotypic Plasticity in Uveal Melanoma Is Not Restricted to a Tumor Subpopulation and Is Unrelated to Cancer Stem Cell Characteristics.

Rachel E Doherty1,2, Karen Sisley1, David W Hammond1, Ian G Rennie3, Neil A Cross2.   

Abstract

Purpose: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and approximately half of those diagnosed will die of metastasis. This study investigates whether UM progression is driven by a subpopulation of stem-like cells, termed "cancer stem cells" (CSCs).
Methods: Expression of postulated stem cell markers aldehyde dehydrogenase (ALDH), CD44, and CD133 was analyzed in UM cell lines and primary UM short-term cultures (STCs) established from tumor samples. Additionally, the notion of a "cellular hierarchy" within UM was investigated. Finally, the phenomenon of phenotypic plasticity in response to environmental factors was explored.
Results: We demonstrate that expression of ALDH, CD44, and CD133 does not select for a subpopulation of stem-like cells in either UM cell lines or UM STCs. Furthermore, there is an absence of a cellular hierarchy in cell lines and all cells in culture are able to drive tumor progression. Last, we show that established UM cell lines and UM STCs are plastic in nature and switch their phenotype in response to environmental stimuli. Conclusions: We hypothesize that this capacity to undergo phenotypic plasticity may be a consequence of neural crest lineage and renders the exploration of the CSC hypothesis extremely challenging in UM.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29049740     DOI: 10.1167/iovs.17-22272

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

Review 1.  Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.

Authors:  Florian Rambow; Jean-Christophe Marine; Colin R Goding
Journal:  Genes Dev       Date:  2019-10-01       Impact factor: 11.361

2.  Verification of EZH2 as a druggable target in metastatic uveal melanoma.

Authors:  Bei Jin; Ping Zhang; Hailin Zou; Huijing Ye; Yun Wang; Jing Zhang; Huasheng Yang; Jingxuan Pan
Journal:  Mol Cancer       Date:  2020-03-04       Impact factor: 27.401

Review 3.  Research Progress of Cancer Stem Cells in Uveal Melanoma.

Authors:  Yu Ning Chen; Yang Li; Wen Bin Wei
Journal:  Onco Targets Ther       Date:  2020-11-27       Impact factor: 4.147

Review 4.  Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma.

Authors:  Mark J de Lange; Rogier J Nell; Pieter A van der Velden
Journal:  Mol Biomed       Date:  2021-08-20

5.  Spheroid-induced heterogeneity and plasticity of uveal melanoma cells.

Authors:  Yao Chen; Xiaoqin Lu; Ling Gao; Douglas C Dean; Yongqing Liu
Journal:  Cell Oncol (Dordr)       Date:  2022-04-11       Impact factor: 7.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.